Published in Nature on September 25, 1980
Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest (2005) 1.95
Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis. J Exp Med (1986) 1.56
The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis. J Clin Immunol (2001) 1.56
B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity. Retrovirology (2009) 1.03
The Charcot Lecture | beating MS: a story of B cells, with twists and turns. Mult Scler (2014) 1.02
Is multiple sclerosis an autoimmune disease? Autoimmune Dis (2012) 0.94
Sequential changes in oligoclonal patterns during the course of multiple sclerosis. J Neurol Neurosurg Psychiatry (1983) 0.90
Analysis of immunoglobulin G in multiple sclerosis brain: quantitative and isoelectric focusing studies. Clin Exp Immunol (1982) 0.88
B cells in multiple sclerosis. Front Biosci (2004) 0.86
Intrathecal synthesis of virus antibodies in multiple sclerosis patients. Infect Immun (1982) 0.82
Antibody to myelin basic protein in extracts of multiple sclerosis brain. Immunology (1981) 0.82
Distribution of nominal and latent IgG (Gm) allotypes in plaques of multiple sclerosis brain. Clin Exp Immunol (1983) 0.81
Do antibodies to myelin basic protein isolated from multiple sclerosis cross-react with measles and other common virus antigens? Clin Exp Immunol (1983) 0.81
Evidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosis. Neurol Res Int (2011) 0.78
Analysis of a predominant immunoglobulin population in the cerebrospinal fluid of a multiple sclerosis patient by means of an anti-idiotypic hybridoma antibody. Proc Natl Acad Sci U S A (1981) 0.77
The retrovirus/superantigen hypothesis of multiple sclerosis. Cell Mol Neurobiol (2014) 0.77
Normal T cell subsets and lymphocyte activity in multiple sclerosis. Clin Exp Immunol (1985) 0.76
Antibodies in multiple sclerosis oligoclonal bands target debris. Proc Natl Acad Sci U S A (2016) 0.76
Sequential changes in oligoclonal patterns during the course of multiple sclerosis. J Neurol Neurosurg Psychiatry (1983) 0.75
What's new in the pathogenesis of multiple sclerosis? A review. J R Soc Med (1989) 0.75
New immunological approaches in treating and diagnosing CNS diseases. Pharm Pat Anal (2013) 0.75
Differences in interaction between immune complexes and complement receptors in serum and cerebrospinal fluid. Clin Exp Immunol (1982) 0.75
Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science (1993) 5.78
The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore) (1969) 4.72
Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis viruses. Virology (1988) 3.17
Induction of tumour immunity with tumour cells treated with iodoacetate. Nature (1966) 2.42
Demyelinative myelopathy in mice induced by the DA virus. J Neurol Sci (1976) 2.20
Neurovirulence determinants of genetically engineered Theiler viruses. Proc Natl Acad Sci U S A (1990) 2.15
Frequency of anti-nuclear antibodies in multiple sclerosis. Neurology (1995) 2.07
Secretion of a nerve growth factor by primary chick fibroblast cultures. Science (1975) 1.88
Failure to detect enterovirus in the spinal cord of ALS patients using a sensitive RT-PCR method. Neurology (2004) 1.83
Alternative translation initiation site in the DA strain of Theiler's murine encephalomyelitis virus. J Virol (1991) 1.79
The initial lesion in experimental allergic neuritis. A phase and electron microscopic study. J Exp Med (1968) 1.68
Novel mutations in spastin gene and absence of correlation with age at onset of symptoms. Neurology (2000) 1.67
Synthesis of nerve growth factor by L and 3T3 cells in culture. Proc Natl Acad Sci U S A (1974) 1.64
DA strain of Theiler's murine encephalomyelitis virus induces demyelination in nude mice. Ann Neurol (1984) 1.62
The leader peptide of Theiler's murine encephalomyelitis virus is a zinc-binding protein. J Virol (1995) 1.60
The effect of short-term and chronic immunosuppression on Theiler's virus demyelination. J Neuroimmunol (1982) 1.57
Cell-specific proteins regulate viral RNA translation and virus-induced disease. EMBO J (2001) 1.56
Strains from both Theiler's virus subgroups encode a determinant for demyelination. J Virol (1990) 1.53
Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b. Neurology (1995) 1.53
Involvement of cardiovirus leader in host cell-restricted virus expression. Proc Natl Acad Sci U S A (1994) 1.52
The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2003) 1.49
Isoelectric focusing studies of serum and cerebrospinal fluid in patients with antecedent poliomyelitis. Ann Neurol (1989) 1.48
Frequency and significance of antinuclear antibodies in multiple sclerosis. Neurology (1997) 1.48
Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J Neuroimmunol (1991) 1.46
Virus-induced abortion. Studies of equine herpesvirus 1 (abortion virus) in hamsters. Lab Invest (1975) 1.45
Idiopathic polyneuritis after surgery. Arch Neurol (1968) 1.43
A single amino acid change determines persistence of a chimeric Theiler's virus. J Virol (1994) 1.42
Neutralizing monoclonal antibodies to Theiler's murine encephalomyelitis viruses. J Virol (1985) 1.41
Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection. J Virol (1991) 1.40
Multiple sclerosis: additional thoughts. J Neurol Sci (1992) 1.38
Amyotrophic lateral sclerosis and life-sustaining therapy: patients' desires for information, participation in decision making, and life-sustaining therapy. Mayo Clin Proc (1991) 1.37
Characterization of a cell culture persistently infected with the DA strain of Theiler's murine encephalomyelitis virus. J Virol (1982) 1.37
Secretion of a nerve growth factor by mouse neuroblastoma cells in culture. Proc Natl Acad Sci U S A (1975) 1.36
Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes. N Engl J Med (1976) 1.36
S-100 protein in human chondrocytes. Nature (1982) 1.35
Interferon beta in multiple sclerosis. Neurology (1993) 1.35
Studies on the mechanism of action of nerve growth factor. Proc Natl Acad Sci U S A (1972) 1.32
A protein critical for a Theiler's virus-induced immune system-mediated demyelinating disease has a cell type-specific antiapoptotic effect and a key role in virus persistence. J Virol (1998) 1.32
A picornaviral protein synthesized out of frame with the polyprotein plays a key role in a virus-induced immune-mediated demyelinating disease. Nat Med (1995) 1.31
Trypsin-sensitive neutralization site on VP1 of Theiler's murine encephalomyelitis viruses. J Virol (1988) 1.31
Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1, encodes a 28-kDa protein: a possible autoantigen for HTLV-I gag-reactive autoantibodies. Proc Natl Acad Sci U S A (1992) 1.30
Relationship of Theiler's murine encephalomyelitis viruses to the cardiovirus genus of picornaviruses. Intervirology (1986) 1.30
Cell-mediated demyelination of peripheral nerve in tissue culture. Lab Invest (1969) 1.28
Experimental autonomic neuropathy: an immunologically induced disorder of reflex vasomotor function. J Neurol Neurosurg Psychiatry (1965) 1.26
Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB. J Neurosci (1999) 1.24
Suppressor cell function in multiple sclerosis. Ann Immunol (Paris) (1978) 1.22
Suppressor cell function in multiple sclerosis: correlation with clinical disease activity. Ann Neurol (1979) 1.17
L* protein of the DA strain of Theiler's murine encephalomyelitis virus is important for virus growth in a murine macrophage-like cell line. J Virol (1998) 1.16
Patients with amyotrophic lateral sclerosis receiving long-term mechanical ventilation. Advance care planning and outcomes. Chest (1996) 1.16
Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference. Neurology (1996) 1.15
Circulating suppressor cells in man as a function of age. Clin Immunol Immunopathol (1978) 1.13
Influence of Theiler's murine encephalomyelitis virus 5' untranslated region on translation and neurovirulence. J Virol (1992) 1.13
Localization of a neutralization site of Theiler's murine encephalomyelitis viruses. J Virol (1985) 1.13
Amyotrophic lateral sclerosis with antecedent poliomyelitis. Arch Neurol (1980) 1.13
The measurement of ambulatory impairment in multiple sclerosis. Neurology (1997) 1.11
Home ventilation for amyotrophic lateral sclerosis patients: outcomes, costs, and patient, family, and physician attitudes. Neurology (1993) 1.11
Pathogenesis of early and late disease in mice infected with Theiler's virus, using intratypic recombinant GDVII/DA viruses. J Virol (1992) 1.11
Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection. J Neurosci (1997) 1.09
Changes in concanavalin A capping of human lymphocytes with age. Mech Ageing Dev (1980) 1.09
A Theiler's virus alternatively initiated protein inhibits the generation of H-2K-restricted virus-specific cytotoxicity. J Immunol (1999) 1.08
Comparison of agar gel electrophoresis and isoelectric focusing in multiple sclerosis and subacute sclerosing panencephalitis. Ann Neurol (1981) 1.08
The cost-effectiveness of magnetic resonance imaging for patients with equivocal neurological symptoms. Int J Technol Assess Health Care (1997) 1.07
Cell-mediated immunity in polymyositis. Creatine phosphokinase release from muscle cultures. Arch Neurol (1974) 1.07
Regulation of excitatory transmission at hippocampal synapses by calbindin D28k. Proc Natl Acad Sci U S A (1995) 1.06
Linear IgA bullous dermatosis in association with multiple sclerosis. J Am Acad Dermatol (1994) 1.06
A monoclonal antibody against human T suppressor lymphocytes binds specifically to the surface of cultured oligodendrocytes. Nature (1982) 1.05
Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis. J Exp Med (1994) 1.05
Histocompatibility types and measles antibodies in multiple sclerosis and optic neuritis. J Neurol Sci (1974) 1.05
Monoclonal antibodies against purified nicotinic acetylcholine receptor. Biochem Biophys Res Commun (1979) 1.04
Viral infectious complementary-DNA studies may identify nonviral genes critical to central nervous system disease. Ann Neurol (1989) 1.01
Effect of oral contraceptives on experimental demyelinating disease. Arch Neurol (1969) 1.01
Interferon gamma- and interleukin-4-secreting cells in multiple sclerosis. J Neuroimmunol (1993) 1.01
Chimeric cDNA studies of Theiler's murine encephalomyelitis virus neurovirulence. J Virol (1993) 1.01
Linkage analysis in familial amyotrophic lateral sclerosis. Neurology (1989) 1.00
Sporadic corticosteroid pulses and osteoporosis in multiple sclerosis. Arch Neurol (1996) 1.00
CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses. Gene Ther (1995) 1.00
Neuropathy accompanying IgM lambda monoclonal gammopathy. Acta Neuropathol (1983) 1.00
Nicotinic acetylcholine receptor: evidence for a functionally distinct receptor on human lymphocytes. Proc Natl Acad Sci U S A (1979) 0.99
A study of B and T cells in multiple sclerosis. Neurology (1975) 0.99
Familial spastic paraparesis syndrome associated with HTLV-I infection. N Engl J Med (1990) 0.99
Detection of in vivo stimulated cerebrospinal-fluid lymphocytes by flow cytometry in patients with multiple sclerosis. N Engl J Med (1980) 0.99
A neutralization site of DA strain of Theiler's murine encephalomyelitis virus important for disease phenotype. Virology (1996) 0.98
EAN as a model for idiopathic polyneuritis. Trans Am Neurol Assoc (1968) 0.96
Secretion of nerve growth factor by central nervous system glioma cells in culture. J Cell Biol (1977) 0.95
Cell-mediated immunity in idiopathic polyneuritis. Ann Neurol (1981) 0.95
Restriction of measles virus gene expression in measles inclusion body encephalitis. J Infect Dis (1988) 0.95
Idiopathic polyneuritis (Landry-Guillain-Barré-Strohl syndrome) and experimental allergic neuritis: a comparison. Res Publ Assoc Res Nerv Ment Dis (1971) 0.95
Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b. Neurology (1996) 0.94
Neuromuscular transmission in amyotrophic lateral sclerosis. Muscle Nerve (1993) 0.94
Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons. Mol Pharmacol (1996) 0.94
Suppression of RNA synthesis in lymphocytes by inhibitors of proteolytic enzymes. Exp Cell Res (1974) 0.94
Influence of azathioprine (imuran) on in vitro immune function in multiple sclerosis. Ann Neurol (1982) 0.94
Comparison of sympathetic skin response with quantitative sudomotor axon reflex test in diabetic neuropathy. Muscle Nerve (1989) 0.93
Conditioning of cyclophosphamide-induced leukopenia in humans. J Neuropsychiatry Clin Neurosci (1996) 0.93
Immunologic and virologic studies of measles inclusion body encephalitis in an immunosuppressed host: the relationship to subacute sclerosing panencephalitis. Neurology (1981) 0.93